CDKN2B rs7039467: Longevity and the 9p21 Locus
rs7039467 is a common noncoding single nucleotide polymorphism located in the CDKN2B gene region on chromosome 9p21. Genome-wide association studies have identified this genomic neighborhood as an important regulator of cellular senescence, vascular health, and human healthspan. Carrying specific alleles at this locus has been moderately linked to differences in survival into advanced age, primarily through its influence on pathways governing cell division and age-related tissue maintenance.
What each genotype means
Typical longevity baseline
You carry two copies of the C allele at this locus in the CDKN2B region. In genome-wide association studies evaluating parental lifespan and survival past age 90, this genotype is considered the baseline profile and is not enriched for the longevity-promoting signal. Longevity is complex and influenced by many lifestyle, environmental, and genetic factors beyond this single marker.
Carried by roughly 30% to 35% of individuals of European ancestry, though frequencies differ across other ancestral populations.
Moderate longevity association
You have one copy of the T allele associated with cellular senescence modulation at chromosome 9p21. Cohort studies of parental attained age and exceptional survival have observed modest positive associations between this allele and lifespan extension. However, this statistical correlation represents a slight increase in odds of reaching extreme age rather than a guarantee of healthspan or survival.
Carried by approximately 45% to 50% of individuals of European ancestry, representing the most common genotype in this group.
Increased longevity association
You carry two copies of the T allele linked to altered expression in the CDKN2A/CDKN2B senescence pathway. Research investigating long-lived cohorts and parental survival has associated this homozygous genotype with higher relative odds of survival beyond age 90 compared to the baseline genotype. This reflects a statistical population tendency, and overall healthspan continues to be shaped by many other genetic and lifestyle contributors.
Found in about 15% to 20% of individuals of European descent, with varying prevalence across diverse global populations.
Genomic Location and Variant Characteristics
The single nucleotide polymorphism rs7039467 resides on chromosome 9p21, situated within or adjacent to the Cyclin Dependent Kinase Inhibitor 2B (CDKN2B) gene. Rather than directly changing the amino acid sequence of a protein, rs7039467 is a noncoding regulatory variant. Variants in this genomic sector often influence how nearby genes are transcribed, spliced, or coordinated across the broader 9p21 cluster. This specific region of chromosome 9 has garnered significant scientific attention because it acts as an epicenter for regulatory elements controlling cell cycle dynamics. Regulatory changes here can modulate cellular senescence—the natural process whereby cells permanently cease dividing in response to stress, damage, or replicative limits. While individual single nucleotide changes in noncoding regions exert modest biological effects on their own, they often serve as key markers of expression variation across neighboring tumor suppressor genes.
Biological Role of the CDKN2B Locus
CDKN2B encodes the tumor suppressor protein p15INK4b, a cyclin-dependent kinase inhibitor that blocks cell cycle progression from the G1 phase into the S phase by forming complexes with CDK4 and CDK6. Together with its neighboring genes, CDKN2A and the noncoding RNA CDKN2B-AS1 (also known as ANRIL), this locus acts as a critical checkpoint controlling when human cells stop dividing and enter senescence. Senescence is a double-edged sword in human biology: it acts as a primary defense against malignant cell growth, but the chronic accumulation of senescent cells over decades can promote localized inflammation and tissue degeneration. Variations across the 9p21 cluster, including rs7039467, can alter the baseline sensitivity of these arrest mechanisms, subtly shifting how tissues manage long-term cellular turnover and vascular repair over an individual's lifetime.
Research on Healthspan and Exceptional Longevity
Large-scale biobank cohorts and studies of nonagenarians and centenarians have repeatedly linked the 9p21 region to human survival traits and age-related phenotypes. Research cataloged in longevity databases has identified variations in CDKN2B and CDKN2B-AS1 as contributors to cardiovascular resilience and overall attained lifespan. For example, large investigations using the UK Biobank have confirmed that genetic variation in 9p21 correlates with parental attained age, vascular outcomes, and extended survival past 90 years. However, the evidence for rs7039467 specifically is classified as moderate rather than definitive. In complex traits like lifespan, single variants do not act in isolation; their observed effects are modest, probabilistic, and often mediated by reductions in age-related vascular pathology rather than an independent 'anti-aging' program.
Population Patterns and Genomic Context
According to data from the Genome Aggregation Database (gnomAD), the minor allele for rs7039467 is very common, displaying an estimated minor allele frequency of approximately 0.42 (42%) in populations of European ancestry. Because this variant is widely distributed across general populations, it represents normal human genetic diversity rather than a rare pathogenic mutation. Frequencies can vary across other ancestral backgrounds due to genetic drift and historical demographic shifts. Due to extensive linkage disequilibrium across chromosome 9p21, rs7039467 is inherited in coordinated blocks with several other noncoding markers. Consequently, researchers continue to study whether rs7039467 is the functional driver of regional regulatory effects or whether it tracks closely alongside adjacent functional variants that govern CDKN2B expression.
Interpreting Longevity Genetics
Learning your rs7039467 genotype provides an educational snapshot of one small biological marker among hundreds of thousands of variants that influence healthspan. It cannot diagnose disease, predict your individual lifespan, or guarantee protection from age-related conditions. Exceptional longevity is an inherently polygenic and multifactorial trait governed by hundreds of common genetic variants, lifestyle habits, nutrition, environmental factors, and medical access. No single marker at 9p21 dictates personal health outcomes. Rather than viewing this variant as a fixed determinant of longevity, it is best understood as a window into the biological pathways—such as cellular senescence, cardiovascular maintenance, and tissue renewal—that modern science is actively exploring to understand the aging process.
How common is this variant?
The minor allele frequency for rs7039467 is approximately 0.42 in populations of European ancestry according to gnomAD. It represents a common, standard polymorphism across global populations.
Frequently asked questions
Can testing rs7039467 predict how long I will live?
No. Lifespan is influenced by hundreds of subtle genetic variants, environmental conditions, lifestyle choices, and access to medical care. Having a specific genotype at rs7039467 only reflects a small, statistical association observed across large population studies.
What role does CDKN2B play in the body?
CDKN2B provides instructions for making p15INK4b, a protein that stops cells from dividing uncontrollably by inhibiting cyclin-dependent kinases. This makes it an essential checkpoint in tumor suppression and the natural process of cellular senescence.
Why is the 9p21 chromosomal region so frequently studied?
Chromosome 9p21 houses key cell cycle regulatory genes, including CDKN2A, CDKN2B, and the noncoding RNA ANRIL. Large genetic studies have identified this region as a critical hub influencing coronary artery disease risk, cellular aging, and parental attained lifespan.
Should I make lifestyle or medical changes based on this variant?
No clinical guidelines suggest changing medical care or lifestyle based solely on rs7039467. Standard preventive health practices—such as cardiovascular health maintenance, balanced nutrition, and regular exercise—remain the most effective strategies for promoting healthy aging.
Sources & further reading
Educational information only, last refreshed 9/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs7039467?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in CDKN2B
This variant is located in the CDKN2B-AS1 region and is a well-established risk factor for primary open-angle glaucoma and associated optic disc traits.
This variant is a well-established risk factor for coronary artery disease and related cardiovascular conditions.
This SNP is a well-replicated marker for cardiovascular disease risk and myocardial infarction susceptibility.
This variant is associated with increased risk for coronary artery disease and related cardiovascular conditions.
This SNP has been identified as a susceptibility marker for meningioma risk in genome-wide association studies.